Cargando…

PB2185: EFFECT OF NEW OR WORSENING ANEMIA ON CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX): A POST HOC ANALYSIS OF THE COMFORT-I AND -II TRIALS

Detalles Bibliográficos
Autores principales: Al-Ali, Haifa Kathrin, Mesa, Ruben, Hamer-Maansson, J.E., Braunstein, Evan, Harrison, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429189/
http://dx.doi.org/10.1097/01.HS9.0000975492.85817.f0